Shares of drug firm Wockhardt on Monday plunged 7 per cent after the company reported widening of consolidated net loss to Rs 71.11 crore for the December 2018 quarter.
The stock slumped 7.04 per cent to close at Rs 444.95 on the BSE. During the day, it dropped 10.23 per cent to Rs 429.65.
At the National Stock Exchange (NSE), shares of the company tumbled 7.08 per cent to close at Rs 444.95 apiece.
In terms of equity volume, 3.41 lakh shares of the company were traded on the BSE and over 32 lakh shares changed hands at the NSE during the day.
The company had posted a net loss of Rs 40.76 crore for the corresponding period of 2017-18, Wockhardt said in a BSE filing.
Consolidated revenue from operations stood at Rs 1,045.86 crore for the quarter under consideration, against Rs 1,005.30 crore for the corresponding period a year ago.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)